This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Kim Roennow Sejtzer: Innovator in Injection Device Technology
Introduction
Kim Roennow Sejtzer is a notable inventor based in Fredensborg, Denmark. She has made significant contributions to the field of medical devices, particularly in the development of injection technology. Her innovative approach has led to the creation of a unique device that enhances the delivery of liquid drugs.
Latest Patents
Kim Roennow Sejtzer holds a patent for a torsion spring driven injection device. This invention relates to a device designed for ejecting set doses of a liquid drug. The device features a blocking structure that is operated by a rotatable display element, ensuring that the set dose can only be expelled when a certain minimum dose size has been established. Additionally, the device includes a release mechanism that guarantees the set dose is expelled as a single full dose in one stroke. These features can be combined to ensure that the predetermined minimum dose size is expelled as one single dose.
Career Highlights
Kim is currently employed at Novo Nordisk A/S, a leading global healthcare company. Her work focuses on advancing medical technology to improve patient care and treatment outcomes. With her expertise, she has contributed to the development of innovative solutions in the pharmaceutical industry.
Collaborations
Throughout her career, Kim has collaborated with esteemed colleagues, including Claus Urup Gjoedesen and Niels Christian Egholm Soerensen. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Kim Roennow Sejtzer is a pioneering inventor whose work in injection device technology has the potential to transform the way liquid drugs are administered. Her innovative designs and commitment to improving healthcare make her a valuable asset to the medical device industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
